   
  
G/LIC/N/2/MAC/5  
 
9 November  2022 
(22-8369) Page: 1/2 
Committee on Import Licensing  Original: English  
 
AGREEMENT ON IMPORT LICENSING PROCEDURES  
NOTIFICATION UNDER ARTICLE 5.1 TO 5.4 OF THE AGREEMENT1 
MACAO, CHINA 
The following notification, dated 24 October  2022, is being circulated at the request of the delegation 
of Macao, China.  
 
 Category  Notification details  
1 Notifying Member  Macao, China  
2 Title of new 
legislation/procedure  1. Chief Executive 's Decision No. 209/2021  
2. Organization and functioning of the Pharmaceutical 
Administration Bureau (Administrative Regulation No. 35/2021)  
3 Date of Publication  
 1. 31 December 2021 
2. 25 October 2021 
4 Date of entry into force  All effective from 1  January 2022 
5 Website link/Official 
publication of the new 
regulation/procedure  1. https://images.io.gov.mo/bo/i/2021/52/despce -209-2021.pdf  
 
2. https://images.io.gov.mo/bo/i/2021/43/rega -35-2021.pdf  
6 Have you attached a copy 
of the regulation (PDF) to 
the Secretariat  [✓] Yes. ( Please attach a copy of the regulation to the notification. ) 
 
[ ] No.  
7 Type of notification  [ ] (a) New licensing regulation/procedure2; (please answer question 
8 to 14)  
 
[✓] (b) Changes to a regulation/procedure which has been 
previously notified in document: G/LIC/N/1/MAC/7 ; (please answer 
questi on 15 and 16 ) 
8 List of products subject to 
licensing  Please provide the HS codes and detailed descriptions of the 
products. In case of a long list, please attach the list as an Annex in 
MS WORD document.  
9 Nature of licensing  Automatic: []  
 
Non-Automatic: []  
10 Administrative 
purpose/measure being 
implemented  (a)  Protect public morals;  
(b)  Protect human, animal or plant life and health; protect 
environment;  
(c)  Collect trade statistics or market surveillance;  
(d)  Protection of patents, trademarks and copyrights, and 
the prevention of deceptive practices;  
(e)  Pursue obligations under the UN Charter and other 
international treaties ( i.e. CITES, Basel Convention, 
Rotterdam Convention, UNSC Resolutions etc.)  
 
1 It is understood that the notifying Member has also completed its notification obligations under 
Article  1.4(a) and Article 8.2(b) regarding the relevant law/regulation/procedure notified for by filling this form 
in a full and complete manner.  
2 "New licensing regulation/procedure" is understood to refer to any newly introduced law, regulation or 
procedure, and those which are in force but being no tified for the first time to the Committee.  G/LIC/N/2/MAC/5  
 
- 2 - 
 
   Category  Notification details  
(f)  Quota (including TRQ) administration;  
(g)  Regulate imports of arms, ammunition or fissionable 
materials and safeguard national security;  
(h)  Other: ______________ (please specify)  
11 Administrative body(ies) 
for submission of 
applications    
12 Contact point for 
information on eligibility   
13 Expected duration of 
licensing procedure   
 
14 A summary of the 
notification in one of the 
WTO official languages    
15 In the case of 7(b), please 
indicate the type of new 
change(s)  (a)  Termination  
(b)  Suspension  
(c)  Modification of specific details in existing  
procedures:  
 Product coverage;  
 Administrative purpose;  
 Automatic or Non -automatic;  
 Duration of licensing;  
 Change the nature of quantity/value restriction;  
 Eligibility of applicants;  
 Contact information on eligibility;  
 Administrative body(ies) for submission of application;  
 Documentation requirements (including application form);  
 Period for Application;  
 Administrative body(ies) to issue licence;  
 Processing time for issuing licence;  
 Licence fee/administrative charge;  
 Deposit/advance payment and relevant conditions;  
 Appeal regulations/procedures;  
 Validity of licence;  
 Other conditions of licence (extension, transferability, 
penalty of non -use etc.);  
 Foreign exchange requirements;  
 Other: __________ (please specify).  
 
16  Please elaborate the 
changes in detail (in one of 
the WTO official languages)  
 1. Chief Executive 's Decision No. 209/2021 divides group B of 
Table B referred to in Paragraph 4, Article 9 of Law No. 7/2003 
into B1 and B2, and includes toxic Chinese medicinal materials, 
prepared portions or extracts and general Chinese medicinal 
materials, prepared portions or extracts in group B1.  
 
2. According to Administ rative Regulation No. 28/2003 as revised  
by Administrative Regulation No. 19/2016 and Administrative 
Regulation No. 35/2021, the authority to issue import licenses 
for goods listed in group B1 of Table B is vested in the 
Pharmaceutical Administration Burea u. 
 
__________  